APA (7th ed.) Citation

Rombach, I., Wang, K., Tonner, S., Grabey, J., Harnden, A., Wolstenholme, J., & Group, A. C. (2022). Quality of life, healthcare use and costs in ‘at-risk’ children after early antibiotic treatment versus placebo for influenza-like illness: Within-trial descriptive economic analyses of the ARCHIE randomised controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Rombach, I., K. Wang, S. Tonner, J. Grabey, A. Harnden, J. Wolstenholme, and ARCHIE Collaborators Group. Quality of Life, Healthcare Use and Costs in ‘at-risk’ Children After Early Antibiotic Treatment Versus Placebo for Influenza-like Illness: Within-trial Descriptive Economic Analyses of the ARCHIE Randomised Controlled Trial. BMJ Publishing Group, 2022.

MLA (9th ed.) Citation

Rombach, I., et al. Quality of Life, Healthcare Use and Costs in ‘at-risk’ Children After Early Antibiotic Treatment Versus Placebo for Influenza-like Illness: Within-trial Descriptive Economic Analyses of the ARCHIE Randomised Controlled Trial. BMJ Publishing Group, 2022.